Federal Register / Vol. 83, No. 174 / Friday, September 7, 2018 / Notices 45449 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning of and annually during their 

terms. NIOSH identifies potential 

candidates and provides a slate of 

nominees for consideration to the 

Director of CDC for STAC membership 

each year; CDC reviews the proposed 

slate of candidates, and provides a slate 

of nominees for consideration to the 

Secretary of HHS for final selection. 

HHS notifies selected candidates of 

their appointment near the start of the 

term in October, or as soon as the HHS 

selection process is completed. Note 

that the need for different expertise 

varies from year to year and a candidate 

who is not selected in one year may be 

reconsidered in a subsequent year. 

Candidates should submit the 

following items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address); 

D The category of membership 

(environmental medicine or 

environmental health specialist, 

occupational physician, pulmonary 

physician, representative of WTC 

responders, representative of certifiedeligible WTC survivors, industrial 

hygienist, toxicologist, epidemiologist, 

or mental health professional) that the 

candidate is qualified to represent; 

D A summary of the background, 

experience, and qualifications that 

demonstrates the candidate’s suitability 

for the nominated membership category; 

and 

D At least one letter of 

recommendation from a person(s) not 

employed by HHS. (Candidates may 

submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–19418 Filed 9–6–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0134; Docket No. CDC–2018– 

0078] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Foreign Quarantine Regulations, 

an information collection related to 

illness and death reports from airplanes 

and maritime vessels coming to the 

United States, illness and death 

investigations of travelers, and 

information from importers of certain 

items specified under 42 CFR 71 

subpart F. 

DATES: CDC must receive written 

comments on or before November 6, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0078 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Foreign Quarantine Regulations (42 

CFR 71) (OMB Control No. 0920–0134) 

(Exp 5/31/2019)—Revision—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Section 361 of the Public Health 

Service Act (PHSA) (42 U.S.C. 264) 

(Attachment A1) authorizes the 

Secretary of Health and Human Services 

to make and enforce regulations 

necessary to prevent the introduction, 

transmission or spread of communicable 

diseases from foreign countries into the 

United States. Statute and the existing 


daltland on DSKBBV9HB2PROD with NOTICES
45450 Federal Register / Vol. 83, No. 174 / Friday, September 7, 2018 / Notices 

regulations governing foreign quarantine 

activities (42 CFR 71) authorize 

quarantine officers and other personnel 

to inspect and undertake necessary 

control measures with respect to 

conveyances, persons, and shipments of 

animals and etiologic agents in order to 

protect the public’s health. Other 

inspection agencies, such as Customs 

and Border Protection (CBP), assist 

quarantine officers in public health 

screening of persons, pets, and other 

importations of public health 

importance and make referrals to 

quarantine station staff when indicated. 

These practices and procedures ensure 

protection against the introduction and 

spread of communicable diseases into 

and within the United States with a 

minimum of recordkeeping and 

reporting procedures, as well as a 

minimum of interference with trade and 

travel. 

U.S. Quarantine Stations are located 

at 20 ports of entry and land-border 

crossings where international travelers 

arrive. The jurisdiction of each station 

includes air, maritime, and/or landborder ports of entry. Quarantine 

Station staff work in partnership with 

international, federal, state, and local 

agencies and organizations to fulfill 

their mission to reduce morbidity and 

mortality among globally mobile 

populations. This work is performed to 

prevent the introduction, transmission, 

and spread of communicable diseases 

from foreign countries into the United 

States or from one State or possession to 

another State or possession. When an 

illness suggestive of a communicable 

disease is reported by conveyance 

operators or port partners (e.g., Customs 

and Border Protection), Quarantine 

Officers respond to carry out an onsite 

public health assessment and collect 

data from the individual. This response 

may occur jointly with port partners. 

The collection of comprehensive, 

pertinent public health information 

during these responses enables 

Quarantine Officers to make an accurate 

public health assessment and identify 

appropriate next steps. For this reason, 

quarantine station staff need to 

systematically interview ill travelers 

and collect relevant health and 

epidemiologic information. 

CDC is making a number of changes 

and adjustments to this information 

collection. The changes are as follows: 

• CDC is merging this information 

collection with another, 0920–0821 

Illness Response Forms: Airline, 

Maritime, and Land/Border Crossing. 

• CDC is disaggregating the 

information collection 42 CFR 71.21(a) 

report of illness or death from ships so 

that the influenza like illness (ILI) 

report, which is voluntary, is separate 

from the required report of ill person or 

death. 

• CDC is removing the information 

collection pertaining to Partner 

Government Agency Message Sets, 

because CDC will not collect 

information using these tools. 

• CDC is removing the acute 

gastroenteritis reports from ships and 

removal of medical logs information 

collection from this information 

collection request, because CDC’s Vessel 

Sanitation Program will submit a 

separate information collection request 

for these tools. 

CDC is requesting the following 

adjustments 

• As described above, CDC is 

requesting a separation of the maritime 

(ILI) and other maritime illness or death 

reports. CDC is also requesting an 

increase in the total number of maritime 

reports of illness of each type, ILI and 

others. 

• For fall 2018, CDC is considering a 

policy change related to requirements 

for rabies vaccination documentation for 

dogs coming from certain countries; 

therefore, CDC is providing estimates of 

burden and respondents related to 

importation of dogs into the United 

States. 

• Revised estimates under 42 CFR 

71.55, 42 CFR 71.32 Dead Bodies— 

Death certificates. 

• Revised estimate of the number of 

requests for exemptions for importation 

of African rodents. 

Respondents for this information 

collection request are any pilot in 

command of an aircraft or maritime 

vessel operator. With an ill person 

meeting certain criteria, or death aboard; 

any individual who is subject to federal 

quarantine or isolation; any ill traveler 

who is reported by the airlines, Customs 

and Border Protection, or EMS to CDC 

or the local public health authority that 

meets the definition of ill person; and 

any importer or filer who seeks to bring 

certain animals, animal products, or 

other CDC-regulated item into the 

United States. 

For most of these collections, there 

are no costs to respondents other than 

their time. Examinations of imported 

animals is only required if the pet is ill 

on arrival or if it has died during 

transport. These exams are not routine. 

Depending on the time of arrival, the 

initial exam fee may be between $100 

and $200. Rabies testing on a dog that 

dies may be between $50 and $100. The 

expected number of ill or dead dogs 

arriving into the United States for which 

CDC may require an examination is 

estimated at less than 30 per year. CDC 

is requesting a three-year approval. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Regulatory provision or form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

hours 

Maritime Vessel Operator ...... 42 CFR 71.21(a) report of illness or death from ships—Maritime 

Conveyance Illness or Death Investigation Form sections 1–4.

500 1 5/60 42 

Maritime Vessel Operator ...... 42 CFR 71.21(a) report of illness or death from ships—Maritime 

Conveyance Illness or Death Investigation Form section 5.

100 1 2/60 3 

Maritime Vessel Operator ...... Cumulative Influenza/Influenza-Like Illness (ILI) .......................... 3,000 1 2/60 100 

Pilot in command ................... 42 CFR 71.21(b) Death/Illness reports from aircrafts .................. 1,700 1 2/60 57 

Traveler .................................. Airline Travel Illness or Death Investigation Form ....................... 1,700 1 5/60 142 

Traveler .................................. Land Travel Illness or Death Investigation Form ......................... 100 1 5/60 8 

Isolated or Quarantined individuals.42 CFR 71.33 Report by persons in isolation or surveillance ..... 11 1 3/60 1 

Maritime Vessel Operator ...... 42 CFR 71.35 Report of death/illness during stay in port ........... 5 1 30/60 3 

Importer .................................. 42 CFR 71.51(c)(1), (d)—Valid Rabies Vaccination Certificates 113,500 1 15/60 28,375 

Importer .................................. CDC Form 75.37 Notice To Owners And Importers Of Dogs: 

Requirement for Dog Confinement.

14 1 10/60 2 

Importer .................................. 42 CFR 71.51(c)(i), (ii), and (iii) exemption criteria for the importation of a dog without a rabies vaccination certificate.958,000 1 15/60 239,500 

Importer .................................. 42 CFR 71.51(c)(2), (d) Application For Permission To Import A 

Dog Inadequately Against Rabies.

50 1 45/60 38 

Importer .................................. 42 CFR 71.51(b)(3) Dogs/cats: Record of sickness or deaths .... 20 1 15/60 5 

Importer .................................. 42 CFR 71.52(d) Turtle Importation Permits ................................ 5 1 30/60 3


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 174 / Friday, September 7, 2018 / Notices 45451 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Regulatory provision or form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

hours 

Importers ................................ 42 CFR 71.55 Dead Bodies, 42 CFR 71.32—Death certificates 20 1 1 20 

Importer .................................. 42 CFR 71.56 (a)(2) African Rodents—Request for exemption .. 25 1 1 25 

Importer .................................. 42 CFR 71.56(a)(iii) Appeal ......................................................... 2 1 1 2 

Importer .................................. 42 CFR 71.32 Statements or documentation of non-infectiousness.2,000 1 5/60 167 

Total ................................ ....................................................................................................... ........................ ........................ ........................ 268,493 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–19381 Filed 9–6–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–18CI] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Evaluation of 

TransLife Center (TLC): A LocallyDeveloped Combination Prevention 

Intervention for Transgender Women at 

High Risk of HIV Infection’’ to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on January 

30, 2018 to obtain comments from the 

public and affected agencies. CDC 

received one (1) comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

Evaluation of TransLife Center (TLC): 

A Locally-Developed Combination 

Prevention Intervention for Transgender 

Women at High Risk of HIV Infection— 

New—National Center for HIV/AIDS, 

Viral Hepatitis, STD and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Center for HIV/AIDS, 

Viral Hepatitis, STD and TB Prevention 

is requesting approval for 24 months of 

data collection entitled, ‘‘Evaluation of 

TransLife Center (TLC): A LocallyDeveloped Combination Prevention 

Intervention for Transgender Women at 

High Risk for HIV Infection.’’ The 

purpose of this study is to evaluate the 

efficacy of TLC, which provides 

combination (biomedical, behavioral 

and social/structural) HIV prevention 

and care services to adult transgender 

women at high risk for HIV infection, in 

a culturally specific and accessible 

environment. The information collected 

through this study will be used to 

evaluate whether the TLC intervention 

is an effective HIV-prevention strategy 

by assessing whether exposure to TLC 

services results in improvements in 

participants’ health and HIV prevention 

behaviors. The trial will assess whether 

intervention participants’ behaviors 

significantly change from baseline to 4- 

and 8-month follow-up periods. 

This study will be carried out in 

Chicago, Illinois, where the TLC 

program is located. The study 

population will include 150 HIVnegative adult transgender women 

living in the Chicago metropolitan area. 

Participants will be at least 18 years of 

age; self-identify as transgender, 

transsexual, women and/or female who 

was assigned male sex at birth; and have 

a self-reported history of sex with men 

in the past four months. The study 

population will also include 10 TLC 

staff members. Staff members will be 

adults, involved in the delivery of TLC 

intervention services. Participation in 

this study is voluntary. 

We anticipate enrollment of a diverse 

sample of transgender women 

comprised mainly of racial/ethnic 

minority participants under 35 years of 

age, consistent with the current TLC 

program and the epidemiology of HIV 

infection among transgender women. 

Intervention participants will be 

recruited to the study through a 

combination of approaches, including 

traditional print advertisement, referral, 

in-person outreach, and through word of 

mouth. TLC staff members will be 

randomly selected to participate in the 

evaluation. 

A computer-assisted quantitative 

assessment will be used to collect 

information for this study, which will 

be delivered at the time of study 

enrollment and again at 4-month and 8- 

month follow-ups. The assessment will 

be used to measure changes in sexual 

risk behavior including condom use and 

pre-exposure prophylaxis (PrEP) care 

engagement. Intervention mediators, 

including gender affirmation, collective 

self-esteem and social support, and 

intervention satisfaction will also be 


daltland on DSKBBV9HB2PROD with NOTICES